Filing Details

Accession Number:
0001209191-14-009072
Form Type:
4
Zero Holdings:
No
Publication Time:
2014-02-11 15:54:38
Reporting Period:
2014-02-10
Filing Date:
2014-02-11
Accepted Time:
2014-02-11 15:54:38
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1571498 Epizyme Inc. EPZM Pharmaceutical Preparations (2834) 261349956
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1134655 Ansbert Gadicke C/o Mpm Asset Management
200 Clarendon Street, 54Th Floor
Boston MA 02116
No No Yes No
1134657 Luke Evnin C/o Mpm Asset Management
200 Clarendon Street, 54Th Floor
Boston MA 02116
No No Yes No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2014-02-10 466,666 $29.25 2,413,819 No 4 S Indirect See footnote
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Indirect See footnote
Footnotes
  1. The shares were sold as follows: 377,313 by MPM BioVentures IV-QP, L.P. ("BV IV QP"), 14,536 by MPM BioVentures IV GmbH & Co. Beteiligungs KG ("BV IV KG"), 10,729 by MPM Asset Management Investors BV4 LLC ("AM BV4") and 64,088 shares by MPM BioVentures IV Strategic Fund, L.P. ("BV IV SF"). MPM BioVentures IV GP LLC and MPM BioVentures IV LLC ("BV LLC") are the direct and indirect general partners of BV IV QP, BV IV KG and BV IV SF and BV LLC is the manager of AM BV4. Ansbert Gadicke, Luke Evnin, Vaughn M. Kailian,James Paul Scopa and Todd Foley are the members of BV LLC.
  2. The shares are held as follows: 1,951,645 by BV IV QP, 75,188 by BV IV KG, 55,495 by AM BV4 and 331,491 shares by BV IV SF. Each Reporting Person disclaims beneficial ownership of the securities except to the extent of his or its respective pecuniary interest therein.